Teconin^TM

Indication:
Teconin^TM is indicated in adults and in children of the following infections- Complicated skin and soft tissue infections, Bone and joint infections, Hospital acquired pneumonia, Community acquired pneumonia, Complicated urinary tract infections, Infective endocarditis.
Teconin^TM is also indicated as an alternative oral treatment for Clostridium difficile infection-associated Diarrhoea and Colitis. Where appropriate, Teicoplanin should be administered in combination with other antibacterial agents.

Dosage & Administration:
The dosage of Teconin^TM should be adapted on the severity of the infection and patient’s response to treatment.
In adults (Normal kidney function) - On the first day, a dose of 6 mg/kg (generally 400 mg) intravenously is recommended. On the following days, the dose may be 6 mg/kg/day (generally 400 mg) intravenously or 3 mg/kg/day (generally 200 mg) intravenously or intramuscularly as a single daily dose. The highest dose and the intravenous route are recommended for serious infections.
In potentially fatal infections, treatment should be started with 6 mg/kg (usually 400 mg) twice daily for 1 to 4 days (loading dose) and continued with 6 mg/kg/day intravenously on the following days (maintenance dose).

Preparation:
Teconin^TM 200 IM/IV Injection: Each box contains one filled vial of Lyophilized Powder equivalent to 200 mg Teicoplanin BP, one ampoule of 5 ml Water for Injection and one 3ml disposable syringe.

Teconin^TM 400 IM/IV Injection: Each box contains one filled vial of Lyophilized Powder equivalent to 400 mg Teicoplanin BP, one ampoule of 5 ml Water for Injection and one 3ml disposable syringe.